{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:32:24Z","timestamp":1791340344821,"version":"4.3.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G802513"],"award-info":[{"award-number":["G802513"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1197-5","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T10:38:39Z","timestamp":1482489519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis"],"prefix":"10.1186","volume":"18","author":[{"given":"Dobrina N.","family":"Hull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Cooksley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Chokshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7766-6167","authenticated-orcid":false,"given":"Peter C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"key":"1197_CR2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361:888\u201398.","journal-title":"N Engl J Med"},{"key":"1197_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","volume":"223","author":"LA Tesmer","year":"2008","unstructured":"Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87\u2013113.","journal-title":"Immunol Rev"},{"key":"1197_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrrheum.2009.80","volume":"5","author":"F Annunziato","year":"2009","unstructured":"Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Type 17\u00a0T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol. 2009;5:325\u201331.","journal-title":"Nat Rev Rheumatol"},{"key":"1197_CR5","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.4049\/jimmunol.0903271","volume":"184","author":"SR Pickens","year":"2010","unstructured":"Pickens SR, Volin MV, Mandelin AM, Kolls JK, Pope RM, Shahrara S. IL-17 Contributes to angiogenesis in rheumatoid arthritis. J Immunol. 2010;184:3233\u201341.","journal-title":"J Immunol"},{"key":"1197_CR6","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M Chabaud","year":"1999","unstructured":"Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42:963\u201370.","journal-title":"Arthritis Rheum"},{"key":"1197_CR7","doi-asserted-by":"crossref","first-page":"e12516","DOI":"10.1371\/journal.pone.0012516","volume":"5","author":"NJ Gullick","year":"2010","unstructured":"Gullick NJ, Evans HG, Church LD, Jayaraj DM, Filer A, Kirkham BW, et al. Linking power Doppler ultrasound to the presence of Th17 cells in the rheumatoid arthritis joint. PLoS One. 2010;5:e12516.","journal-title":"PLoS One"},{"key":"1197_CR8","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647\u201356.","journal-title":"Arthritis Rheum"},{"key":"1197_CR9","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","volume":"62","author":"J Leipe","year":"2010","unstructured":"Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H, et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 2010;62:2876\u201385.","journal-title":"Arthritis Rheum"},{"key":"1197_CR10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.21749","volume":"54","author":"BW Kirkham","year":"2006","unstructured":"Kirkham BW, Lassere MN, Edmonds JP, Juhasz KM, Bird PA, Lee CS, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 2006;54:1122\u201331.","journal-title":"Arthritis Rheum"},{"key":"1197_CR11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1503\/cmaj.091391","volume":"181","author":"JA Singh","year":"2009","unstructured":"Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, et al. A network meta-analysis of randomised controlled trials of biologics for rheumatoid arthritis: a Cochrane review. CMAJ. 2009;181:787\u201396.","journal-title":"CMAJ"},{"key":"1197_CR12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","volume":"45","author":"KL Hyrich","year":"2006","unstructured":"Hyrich KL, Watson KD, Silman AJ, Symmons DPM, Register TBB. Predictors of response to anti-TNF-\u03b1 therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology. 2006;45:1558\u201365.","journal-title":"Rheumatology"},{"key":"1197_CR13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann RheumDis. 2010;69:964\u201375.","journal-title":"Ann RheumDis"},{"key":"1197_CR14","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3","volume":"42","author":"M Backhaus","year":"1999","unstructured":"Backhaus M, Kamradt T, Sandrock D, Loreck D, Fritz J, Wolf KJ, et al. Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum. 1999;42:1232\u201345.","journal-title":"Arthritis Rheum"},{"key":"1197_CR15","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1529-0131(200109)44:9<2018::AID-ART350>3.0.CO;2-C","volume":"44","author":"M Szkudlarek","year":"2001","unstructured":"Szkudlarek M, Court-Payen M, Strandberg C, Klarlund M, Klausen T, Ostergaard M. Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging. Arthritis Rheum. 2001;44:2018\u201323.","journal-title":"Arthritis Rheum"},{"key":"1197_CR16","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar1904","volume":"8","author":"M Szkudlarek","year":"2006","unstructured":"Szkudlarek M, Klarlund M, Narvestad E, Court-Payen M, Strandberg C, Jensen K, et al. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther. 2006;8:R52.","journal-title":"Arthritis Res Ther"},{"key":"1197_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.10812","volume":"48","author":"M-A D'Agostino","year":"2003","unstructured":"D'Agostino M-A, Said-Nahal R, Hacquard-Bouder C, Brasseur J-L, Dougados M, Breban M. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum. 2003;48:523\u201333.","journal-title":"Arthritis Rheum"},{"key":"1197_CR18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1148\/radiol.2292020206","volume":"229","author":"C Ribbens","year":"2003","unstructured":"Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, Bonnet V, et al. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study. Radiology. 2003;229:562\u20139.","journal-title":"Radiology"},{"key":"1197_CR19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/art.20123","volume":"50","author":"PC Taylor","year":"2004","unstructured":"Taylor PC, Steuer A, Gruber J, Cosgrove DO, Blomley MJ, Marsters PA, et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004;50:1107\u201316.","journal-title":"Arthritis Rheum"},{"key":"1197_CR20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/rheumatology\/kem286","volume":"47","author":"F Salaffi","year":"2008","unstructured":"Salaffi F, Filippucci E, Carotti M, Naredo E, Meenagh G, Ciapetti A, et al. Inter-observer agreement of standard joint counts in early rheumatoid arthritis: a comparison with grey scale ultrasonography\u2014a preliminary study. Rheumatology. 2008;47:54\u20138.","journal-title":"Rheumatology"},{"key":"1197_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard.2007.084251","volume":"68","author":"E Miguel de","year":"2009","unstructured":"de Miguel E, Cobo T, Munoz-Fernandez S, Naredo E, Uson J, Acebes JC, et al. Validity of enthesis ultrasound assessment in spondyloarthropathy. Ann Rheum Dis. 2009;68:169\u201374.","journal-title":"Ann Rheum Dis"},{"key":"1197_CR22","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/art.23682","volume":"58","author":"E Naredo","year":"2008","unstructured":"Naredo E, Moller I, Cruz A, Carmona L, Garrido J. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2008;58:2248\u201356.","journal-title":"Arthritis Rheum"},{"key":"1197_CR23","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","volume":"205","author":"CA Notley","year":"2008","unstructured":"Notley CA, Inglis JJ, Alzabin S, McCann FE, McNamee KE, Williams RO. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J Exp Med. 2008;205:2491\u20137.","journal-title":"J Exp Med"},{"key":"1197_CR24","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/rheumatology\/keq224","volume":"49","author":"NE Aerts","year":"2010","unstructured":"Aerts NE, De Knop KJ, Leysen J, Ebo DG, Bridts CH, Weyler JJ, et al. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology. 2010;49:2264\u201372.","journal-title":"Rheumatology"},{"key":"1197_CR25","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/annrheumdis-2011-201024","volume":"71","author":"S Alzabin","year":"2012","unstructured":"Alzabin S, Abraham SM, Taher TE, Palfreeman A, Hull D, McNamee K, et al. Incomplete response of inflammatory arthritis to TNF\u03b1 blockade is associated with the Th17 pathway. Ann Rheum Dis. 2012;71:1741\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1197_CR26","first-page":"401","volume":"181","author":"DN Hull","year":"2015","unstructured":"Hull DN, Williams RO, Pathan E, Alzabin S, Abraham S, Taylor PC. Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis. Clin ExpImmunol. 2015;181:401\u20136.","journal-title":"Clin ExpImmunol"},{"key":"1197_CR27","doi-asserted-by":"crossref","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","DOI":"10.1002\/art.1780310302"},{"key":"1197_CR28","first-page":"705","volume":"26","author":"AM Gestel van","year":"1999","unstructured":"van Gestel AM, Anderson JJ, van Riel PL, Boers M, Haagsma CJ, Rich B, et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol. 1999;26:705\u201311.","journal-title":"J Rheumatol"},{"key":"1197_CR29","doi-asserted-by":"crossref","first-page":"R198","DOI":"10.1186\/ar4034","volume":"14","author":"M Seymour","year":"2012","unstructured":"Seymour M, Kelly S, Beals C, Malice M-P, Bolognese J, Dardzinski B, et al. Ultrasound of metacarpophalangeal joints is a sensitive and reliable endpoint for drug therapies in rheumatoid arthritis: results of a randomized, two-center placebo-controlled study. Arthritis Res Ther. 2012;14:R198.","journal-title":"Arthritis Res Ther"},{"key":"1197_CR30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/rheumatology\/ken459","volume":"48","author":"K Ellegaard","year":"2009","unstructured":"Ellegaard K, Torp-Pedersen S, Terslev L, Danneskiold-Sams\u00f8e B, Henriksen M, Bliddal H. Ultrasound colour Doppler measurements in a single joint as measure of disease activity in patients with rheumatoid arthritis\u2014assessment of concurrent validity. Rheumatology. 2009;48:254\u20137.","journal-title":"Rheumatology"},{"key":"1197_CR31","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3899\/jrheum.100322","volume":"37","author":"MJ Larch\u00e9","year":"2010","unstructured":"Larch\u00e9 MJ, Seymour M, Lim A, Eckersley RJ, P\u00e9tavy F, Chiesa F, et al. Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroids. J Rheumatol. 2010;37:2493\u2013501.","journal-title":"J Rheumatol"},{"key":"1197_CR32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0","volume":"44","author":"M Walther","year":"2001","unstructured":"Walther M, Harms H, Krenn V, Radke S, Faehndrich TP, Gohlke F. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 2001;44:331\u20138.","journal-title":"Arthritis Rheum"},{"key":"1197_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1148\/radiol.2251011272","volume":"225","author":"M Walther","year":"2002","unstructured":"Walther M, Harms H, Krenn V, Radke S, Kirschner S, Gohlke F. Synovial tissue of the hip at power Doppler US: correlation between vascularity and power Doppler US signal. Radiology. 2002;225:225\u201331.","journal-title":"Radiology"},{"key":"1197_CR34","first-page":"254","volume":"30","author":"M Seymour","year":"2012","unstructured":"Seymour M, Petavy F, Chiesa F, Perry H, Lukey PT, Binks M, et al. Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa clinical trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis. Clin Exp Rheumatol. 2012;30:254\u201361.","journal-title":"Clin Exp Rheumatol"},{"key":"1197_CR35","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1","volume":"41","author":"EM Paleolog","year":"1998","unstructured":"Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum. 1998;41:1258\u201365.","journal-title":"Arthritis Rheum"},{"key":"1197_CR36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clim.2007.08.013","volume":"126","author":"M Wong","year":"2008","unstructured":"Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, et al. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol. 2008;126:121\u201336.","journal-title":"Clin Immunol"},{"key":"1197_CR37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","volume":"43","author":"PC Taylor","year":"2000","unstructured":"Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, et al. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum. 2000;43:38\u201347.","journal-title":"Arthritis Rheum"},{"key":"1197_CR38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.1780390702","volume":"39","author":"PP Tak","year":"1996","unstructured":"Tak PP, Taylor PC, Breedveld FC, Smeets TJM, Daha MR, Kluin PM, et al. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor \u03b1 monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:1077\u201381.","journal-title":"Arthritis Rheum"},{"key":"1197_CR39","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/art.11098","volume":"48","author":"TJM Smeets","year":"2003","unstructured":"Smeets TJM, Kraan MC, van Loon ME, Tak P-P. Tumor necrosis factor \u03b1 blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum. 2003;48:2155\u201362.","journal-title":"Arthritis Rheum"},{"key":"1197_CR40","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.4049\/jimmunol.0902245","volume":"185","author":"RJ Eli\u00e7abe","year":"2010","unstructured":"Eli\u00e7abe RJ, Cargnelutti E, Serer MI, Stege PW, Valdez SR, Toscano MA, et al. Lack of TNFR p55 results in heightened expression of IFN-\u03b3 and IL-17 during the development of reactive arthritis. J Immunol. 2010;185:4485\u201395.","journal-title":"J Immunol"},{"key":"1197_CR41","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/ar3431","volume":"13","author":"D-Y Chen","year":"2011","unstructured":"Chen D-Y, Chen Y-M, Chen H-H, Hsieh C-W, Lin C-C, Lan J-L. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther. 2011;13:R126.","journal-title":"Arthritis Res Ther"},{"key":"1197_CR42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/art.38893","volume":"67","author":"PC Taylor","year":"2015","unstructured":"Taylor PC, Williams RO. Editorial: combination cytokine blockade: the way forward in therapy for rheumatoid arthritis? Arthritis Rheumatol. 2015;67:14\u20136.","journal-title":"Arthritis Rheumatol"},{"key":"1197_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/art.38896","volume":"67","author":"JA Fischer","year":"2015","unstructured":"Fischer JA, Hueber AJ, Wilson S, Galm M, Baum W, Kitson C, et al. Combined inhibition of tumor necrosis factor \u03b1 and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody. Arthritis Rheumatol. 2015;67:51\u201362.","journal-title":"Arthritis Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:36:38Z","timestamp":1498358198000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1197-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"303"}}